nadofaragene firadenovec

Merck's Keytruda is bound for new bladder cancer territory. But can it hold up against gene therapy?
Fierce Pharma
Tue, 12/3/19 - 10:42 pm
Keytruda
Merck
FDA
NMIBC
nadofaragene firadenovec
FerGene
gene therapy
Ferring, Blackstone spin out gene therapy with $570M in funding
Fierce Biotech
Mon, 11/25/19 - 09:51 am
Ferring
gene therapy
nadofaragene firadenovec
Blackstone Life Science
bladder cancers